CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
CHina Registry for the chAracteristics and Management strategieS of patiEnts With Pulmonary Hypertension Using Targeted Therapy (CHASE Study)
Eligibility Criteria
Inclusion Criteria: * Sign informed consent; * Between the ages of 18 and 85; * Clinical diagnosis of pulmonary hypertension, using or planning to use pulmonary hypertension targeted drugs (including any one or more of the following: prostacyclin analogues, endothelin receptor antagonists, phosphodiesterase inhibitors, soluble guanylate cyclase agonists and prostacyclin receptor agonists). Exclusion Criteria: * Have a history of mental illness or drug or poison addiction, and can not sign informed consent or can not cooperate with the experimental study; * Patients with malignant tumor and other diseases and life expectancy of less than half a year; * Short-term (less than 2 weeks) patients taking targeted drugs for pulmonary hypertension